Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,377,699
in 4 filings, $108K under 10b5-1 plans

Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-11 NEUPERT PETER M Director Exercise or conversion +742 10,996
2023-02-11 NEUPERT PETER M Director Exercise or conversion · Restricted Stock Unit −742 849
2023-02-11 Parham Richelle P Director Exercise or conversion +742 7,587
2023-02-11 Parham Richelle P Director Exercise or conversion · Restricted Stock Unit −742 849
2023-02-11 Wengel Kathryn E Director Exercise or conversion +742 1,345
2023-02-11 Wengel Kathryn E Director Exercise or conversion · Restricted Stock Unit −742 849
2023-02-11 Williams R Sanders Director Exercise or conversion +742 7,173
2023-02-11 Williams R Sanders Director Exercise or conversion · Restricted Stock Unit −742 849
2023-02-11 BERBERIAN LANCE EVP, CIO & CTO Exercise or conversion +290 20,253
2023-02-11 BERBERIAN LANCE EVP, CIO & CTO Exercise or conversion · Restricted Stock Unit −290 1,827
2023-02-11 Caveney Brian J EVP, President of Diagnostics Exercise or conversion +423 16,536.76
2023-02-11 Caveney Brian J EVP, President of Diagnostics Exercise or conversion · Restricted Stock Unit −423 2,681
2023-02-11 Kirchgraber Paul R CEO, Covance Drug Development Exercise or conversion +483 14,211
2023-02-11 Kirchgraber Paul R CEO, Covance Drug Development Exercise or conversion · Restricted Stock Unit −483 3,001
2023-02-11 EISENBERG GLENN A Chief Financial Officer, EVP Exercise or conversion +723 35,835
2023-02-11 EISENBERG GLENN A Chief Financial Officer, EVP Exercise or conversion · Restricted Stock Unit −723 13,764
2023-02-11 Schechter Adam H President & CEO Exercise or conversion +2,656 24,351
2023-02-11 Schechter Adam H President & CEO Exercise or conversion · Restricted Stock Unit −2,656 16,828
2023-02-11 Schroeder Mark S EVP, President-Diagnostics Lab Exercise or conversion +423 7,110.4
2023-02-11 Schroeder Mark S EVP, President-Diagnostics Lab Exercise or conversion · Restricted Stock Unit −423 2,681

Page 40 of 41 · 816 trades